» Articles » PMID: 29359464

A Prospective Analysis for Prevalence of Complications in Thai Nontransfusion-dependent Hb E/β-thalassemia and α-thalassemia (Hb H Disease)

Overview
Journal Am J Hematol
Specialty Hematology
Date 2018 Jan 24
PMID 29359464
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, complications in patients with nontransfusion-dependent thalassemia (NTDT), in particular those with β-thalassemia intermedia (β-TI), were found to be significantly different from those in patients with transfusion dependent thalassemia (TDT), mainly β-thalassemia major (β-TM). However, this information is rather limited in other forms of NTDT. In this prospective study, adult Thai NTDT patients were interviewed and clinically evaluated for thalassemia related complications. Fifty-seven NTDT patients (age 18-74 years), 59.6% Hb E/β-thalassemia and 40.4% Hb H disease, were recruited; 26.4% were splenectomized. The most common complications were gallstones (68.4%), osteoporosis (26.3%), and pulmonary hypertension (15.8%). Splenectomy was associated with higher rate of gallstones and serious infection (P = .001 and .052, respectively), consistent with a multivariate analysis (RR = 9.5, P = .044, and RR = 15.1, P = .043, respectively). In addition, a higher hemoglobin level was inversely associated with gallstones in both univariate and multivariate analyses (P = .01 and .022, respectively). Serum ferritin was associated with abnormal liver function (P = .002). In contrast to the previous study, the prevalence of thrombosis was less common in our population (1.7%), probably due to differences in transfusion therapy, ethnicity, and underlying genotypes. For the first time, this prospective study provided the current prevalence of NTDT related complications in a Southeast Asian population with a different underlying genetic basis compared with previous studies. Although individual prevalence of each complication might differ from other studies, several important clinical factors such as splenectomy, degree of anemia, and iron overload seem to be determining risks of developing these complications consistently across different ethnicities.

Citing Articles

METTL16 participates in haemoglobin H disease through m6A modification.

Liao Y, Zhang F, Yang F, Huang S, Su S, Tan X PLoS One. 2024; 19(8):e0306043.

PMID: 39088431 PMC: 11293636. DOI: 10.1371/journal.pone.0306043.


A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients.

Petiwathayakorn T, Paradee N, Hantrakool S, Jarujareet U, Intharah T, Srichairatanakool S ACS Appl Bio Mater. 2024; 7(7):4710-4724.

PMID: 38920024 PMC: 11253095. DOI: 10.1021/acsabm.4c00516.


Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemia.

Musallam K, Viprakasit V, Lombard L, Gilroy K, Rane A, Vinals L EJHaem. 2024; 5(3):541-547.

PMID: 38895066 PMC: 11182398. DOI: 10.1002/jha2.882.


Nephrological Complications in Hemoglobinopathies: SITE Good Practice.

Ruffo G, Russo R, Casini T, Lombardini L, Orecchia V, Voi V J Clin Med. 2023; 12(23).

PMID: 38068528 PMC: 10707125. DOI: 10.3390/jcm12237476.


Distinct lipid profile in haemolytic anaemia-related gallstones compared with the general gallstone.

Wan Z, Bai X, He C, Zhang Y, Wang Y, Shen K Ann Med. 2023; 55(1):2203514.

PMID: 37141158 PMC: 10161937. DOI: 10.1080/07853890.2023.2203514.